Fenbendazole (often misspelled fenbendazol) is an antiparasitic drug used to treat parasitic infections in animals. A few studies suggest that it might also suppress cancer cells in petri dishes and mice. The drug appears to interfere with the growth of microtubules, which provide structure to all body cells and are essential for cell division. When the microtubules aren’t growing correctly, chromosomes can’t be separated equally during mitosis, and cancer cells can’t divide.
Researchers have found that fenbendazole can also reduce cancer cell growth by inhibiting glucose uptake. In the study described below, the authors tested how fenbendazole affected sugar uptake in lymphoma cells. They also compared the effect of the drug alone to the effect when it was combined with vitamins. The group that received vitamins and fenbendazole had significantly less tumor volume than the other groups.
Although Joe Tippens’ anecdotal experience with fenbendazole is compelling, it’s important to remember that it’s not scientific evidence. His anecdotal evidence could be the result of other factors that aren’t being accounted for, such as the conventional cancer treatments he was receiving at the time. There’s no evidence from randomized controlled trials that fenbendazole can cure cancer in people, but researchers believe further research is important in order to find drugs that do. Until that happens, patients should follow the advice of their health care providers. They should never stop taking any prescribed medication unless directed to do so by their doctors. fenbendazole for cancer